These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 1850995

  • 21. The novel Ins(1,4,5)P3 analogue 3-amino-3-deoxy-Ins(1,4,5)P3: a pH-dependent Ins(1,4,5)P3 receptor partial agonist in SH-SY5Y neuroblastoma cells.
    Kozikowski AP, Fauq AH, Wilcox RA, Challiss RA, Nahorski SR.
    J Med Chem; 1994 Mar 18; 37(6):868-72. PubMed ID: 8145238
    [Abstract] [Full Text] [Related]

  • 22. Characterization of inositol 1,4,5-trisphosphate-stimulated calcium release from rat cerebellar microsomal fractions. Comparison with [3H]inositol 1,4,5-trisphosphate binding.
    Stauderman KA, Harris GD, Lovenberg W.
    Biochem J; 1988 Oct 15; 255(2):677-83. PubMed ID: 3264497
    [Abstract] [Full Text] [Related]

  • 23. Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes.
    Gregory RB, Hughes R, Riley AM, Potter BV, Wilcox RA, Barritt GJ.
    Biochem J; 2004 Jul 15; 381(Pt 2):519-26. PubMed ID: 15169542
    [Abstract] [Full Text] [Related]

  • 24. Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay.
    Challiss RA, Chilvers ER, Willcocks AL, Nahorski SR.
    Biochem J; 1990 Jan 15; 265(2):421-7. PubMed ID: 2154189
    [Abstract] [Full Text] [Related]

  • 25. Partial purification and reconstitution of inositol 1,4,5-trisphosphate receptor/Ca2+ channel of bovine liver microsomes.
    Kamata H, Hirata M, Ozaki S, Kusaka I, Kagawa Y, Hirata H.
    J Biochem; 1992 Apr 15; 111(4):546-52. PubMed ID: 1319993
    [Abstract] [Full Text] [Related]

  • 26. Molecular target sizes of inositol 1,4,5-trisphosphate receptors in liver and cerebellum.
    Nunn DL, Potter BV, Taylor CW.
    Biochem J; 1990 Jan 15; 265(2):393-8. PubMed ID: 2154187
    [Abstract] [Full Text] [Related]

  • 27. Luminal Ca2+ controls the activation of the inositol 1,4,5-trisphosphate receptor by cytosolic Ca2+.
    Missiaen L, De Smedt H, Droogmans G, Casteels R.
    J Biol Chem; 1992 Nov 15; 267(32):22961-6. PubMed ID: 1331072
    [Abstract] [Full Text] [Related]

  • 28. Inositol trisphosphate receptor localization in brain: variable stoichiometry with protein kinase C.
    Worley PF, Baraban JM, Colvin JS, Snyder SH.
    Nature; 1992 Nov 15; 325(7000):159-61. PubMed ID: 3027583
    [Abstract] [Full Text] [Related]

  • 29. The effects of inositol 1,4,5-trisphosphate (InsP3) analogues on the transient kinetics of Ca2+ release from cerebellar microsomes. InsP3 analogues act as partial agonists.
    Mezna M, Michelangeli F.
    J Biol Chem; 1996 Dec 13; 271(50):31818-23. PubMed ID: 8943223
    [Abstract] [Full Text] [Related]

  • 30. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor.
    Safrany ST, Sawyer DA, Nahorski SR, Potter BV.
    Chirality; 1992 Dec 13; 4(7):415-22. PubMed ID: 1334423
    [Abstract] [Full Text] [Related]

  • 31. Synthetic inositol trisphosphate analogs and their effects on phosphatase, kinase, and the release of Ca2+.
    Hirata M, Watanabe Y, Ishimatsu T, Ikebe T, Kimura Y, Yamaguchi K, Ozaki S, Koga T.
    J Biol Chem; 1989 Dec 05; 264(34):20303-8. PubMed ID: 2555352
    [Abstract] [Full Text] [Related]

  • 32. 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release.
    Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K.
    J Biochem; 1997 Sep 05; 122(3):498-505. PubMed ID: 9348075
    [Abstract] [Full Text] [Related]

  • 33. The inositol 1,4,5-trisphosphate-binding site in adrenal cortical cells is distinct from the endoplasmic reticulum.
    Rossier MF, Capponi AM, Vallotton MB.
    J Biol Chem; 1989 Aug 25; 264(24):14078-84. PubMed ID: 2547781
    [Abstract] [Full Text] [Related]

  • 34. Evidence for the involvement of a small subregion of the endoplasmic reticulum in the inositol trisphosphate receptor-induced activation of Ca2+ inflow in rat hepatocytes.
    Gregory RB, Wilcox RA, Berven LA, van Straten NC, van der Marel GA, van Boom JH, Barritt GJ.
    Biochem J; 1999 Jul 15; 341 ( Pt 2)(Pt 2):401-8. PubMed ID: 10393099
    [Abstract] [Full Text] [Related]

  • 35. Use of phosphorofluoridate analogues of D-myo-inositol 1,4,5-trisphosphate to assess the involvement of ionic interactions in its recognition by the receptor and metabolising enzymes.
    Yoshimura K, Watanabe Y, Erneux C, Hirata M.
    Cell Signal; 1999 Feb 15; 11(2):117-25. PubMed ID: 10048789
    [Abstract] [Full Text] [Related]

  • 36. Regulation of phosphatidylinositide transduction system in the rat spinal cord during aging.
    Igwe OJ, Filla MB.
    Neuroscience; 1995 Dec 15; 69(4):1239-51. PubMed ID: 8848110
    [Abstract] [Full Text] [Related]

  • 37. D-myo-inositol 1,4,5-trisphosphate analogues substituted at the 3-hydroxyl group.
    Hirata M, Watanabe Y, Kanematsu T, Ozaki S, Koga T.
    Biochim Biophys Acta; 1995 Jun 09; 1244(2-3):404-10. PubMed ID: 7599161
    [Abstract] [Full Text] [Related]

  • 38. Two calcium-binding sites mediate the interconversion of liver inositol 1,4,5-trisphosphate receptors between three conformational states.
    Marshall IC, Taylor CW.
    Biochem J; 1994 Jul 15; 301 ( Pt 2)(Pt 2):591-8. PubMed ID: 8043006
    [Abstract] [Full Text] [Related]

  • 39. Purified inositol 1,4,5-trisphosphate receptor mediates calcium flux in reconstituted lipid vesicles.
    Ferris CD, Huganir RL, Supattapone S, Snyder SH.
    Nature; 1989 Nov 02; 342(6245):87-9. PubMed ID: 2554143
    [Abstract] [Full Text] [Related]

  • 40. Acyclophostin: a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacy.
    Beecroft MD, Marchant JS, Riley AM, Van Straten NC, Van der Marel GA, Van Boom JH, Potter BV, Taylor CW.
    Mol Pharmacol; 1999 Jan 02; 55(1):109-17. PubMed ID: 9882704
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.